Language: HOME CHEMICAL COMPOUNDS CENTRE FOR RARE DISEASES BIOECONOMY MEDIA POLICIES AND CERTIFICATIONS CONTACT US News (Italiano) Piero Di Lorenzo presenta al Premier Conte il progetto di High Science... ... 7 FEBRUARY 2020 READ MORE 2019 Winter school “Translational Medicine Explained (TMex)” Scarica il PDF... 15 JULY 2019 READ MORE (Italiano) Piero Di Lorenzo firma il progetto Pronat con CNR e Unitus Sorry, this entry is only available in Italian.... 30 JUNE 2016 READ MORE Di Lorenzo presenta la 4° edizione del Bioeconomy Rome al Quirinale Award Cerimony for "Bioeconomy Rome" was held in Rome, at the "Quirinale"... 16 NOVEMBER 2014 READ MORE ALL NEWS CNCCS Partner in Research The CNCCS is a public-private consortium created in November 2010 by the Italian National Research Council (CNR), the Istituto Superiore di Sanita’ (ISS) and IRBM S.p.A.. CNR, ISS e IRBM S.p.A., are ideal partner in this project because each one contributes with unique and sinergic capacity. Read More The announcement for BIOECONOMY ROME Award will be soon Online Contact Us Ph: +39.06.91093692 Fax: +39.06.91093654 Mail: info@cnccs CNCCS Scarl Collection of National Chemical Compounds and Screening Center Via Pontina km 30,600 – 00071 Pomezia (RM) News (Italiano) Oxford vaccine up to 90% effective – trials (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%» (Italiano) Interview with Matteo Liguori. Research needs time (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people (Italiano) Compliance Privacy Cookies policy Code of Ethics Codice Etico Modello Organizzativo di Gestione e Controllo ex D.Lgs. 231/2001 – Parte generale_allegato Partners

Language: HOME CHEMICAL COMPOUNDS CENTRE FOR RARE DISEASES BIOECONOMY MEDIA POLICIES AND CERTIFICATIONS CONTACT US Edition 2012 Contact Us Ph: +39.06.91093692 Fax: +39.06.91093654 Mail: info@cnccs CNCCS Scarl Collection of National Chemical Compounds and Screening Center Via Pontina km 30,600 – 00071 Pomezia (RM) News (Italiano) Oxford vaccine up to 90% effective – trials (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%» (Italiano) Interview with Matteo Liguori. Research needs time (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people (Italiano) Compliance Privacy Cookies policy Code of Ethics Codice Etico Modello Organizzativo di Gestione e Controllo ex D.Lgs. 231/2001 – Parte generale_allegato Partners